This invention provides compounds of formula I: ##STR00001## wherein a, b, c, m, p, s, t, W, Ar.sup.1, X.sup.1, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.6, and R.sup.7 are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.

 
Web www.patentalert.com

< N-Aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents

> Muscarinic receptor antagonists

~ 00478